OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Prostate Cancer Radiotherapy: HYPO-RT-PC Study Reveals Significant Gaps Between Patient and Clinician Symptom Reporting

SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia

Can Laser Hair Removal Cause Cancer? What Science Says

Timothy Rebbeck: Science Gains a Stronger Voice in the U.S. Congress

Oncology News, Insights, Stories by OncoDaily

LungÕ 2026
Not To Miss

LungÕ 2026: Global Experts Examine the Changing Landscape of Lung Cancer Care

Amivantamab
FDA Approvals

After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer

Solomon Moshkevich
Career Updates

Solomon Moshkevich Named CEO of Natera

Genmab’s Phase 3 LiGeR-HN1 Trial Met Primary Endpoints of Overall Survival and Response Rate in HNSCC

Supermodel Lara Stone Reveals Breast Cancer Diagnosis at 42

Spain Train Crash: Remembering Seven Scientists and Healthcare Professionals Among the Victims

Maira Caleffi on a Lifetime in Cancer Advocacy: ‘I Do One Thing, Many Branches’”

The LIFT Trial: Proving the Power of Embedded Financial Navigators in Rural and Urban Oncology

Health Policy Watch Examines Gevorg Tamamyan’s WHO Bid

From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer

Voices
Chadi Nabhan

Chadi Nabhan's Upcoming Book AI and Cancer Care Will Launch Soon

Ruben Mesa: Our Teams Have Achieved NFP Pancreas Cancer Center of Excellence Designation

Alejandra Mendez: Participate in a Workshop to Ensure That No Child Has to Abandon Cancer Treatment

Fredrick Chite Asirwa։ ICI and Kabarak University Establish Master of Science in Oncology Pharmacy Programme

Miriam Mutebi: Book Club Brunch on Women’s Health and Sisterhood

Bob Li Shares: Discussion on Strengthening Cancer Care in Communities at the ASCO Headquarters

Mel Mann: Personalized mRNA Vaccines Just Cleared a Major Hurdle

FDA Approvals
Amivantamab

After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

Best of MASCC India 2026 – 8th Annual Meeting of Supportive Care in Cancer

Integrated Association of Supportive Care in Cancer (IASCC)

07 Nov
Best of MASCC

Lung Cancer 2026: Precision, Progress, and Practice

HonorHealth

07 Nov
Lung Cancer 2026

TACOS 2026 Advancing Oncology Summit

The Arizona Clinical Oncology Society (TACOS)

07 Nov
TACOS 2026

The ANCO and MOASC Precision Oncology Symposium 2026

Association of Northern California Oncologists (ANCO)

07 Nov
Precision Oncology Symposium

ESTRO Course: Artificial Intelligence in Radiotherapy Clinical Practice

European Society for Radiotherapy and Oncology (ESTRO)

09 Nov
Artificial Intelligence in Radiotherapy

27th Annual IPOS World Congress

International Psycho-Oncology Society (IPOS)

09 Nov
IPOS

SITC Computational Immuno-Oncology – AI Prediction of TCR-Antigen Binding

Society for Immunotherapy of Cancer

09 Nov
TCR-Antigen Binding

ESMO Congress Highlights Webinar – Gastrointestinal Cancers 2026

European Society For Medical Oncology (ESMO)

09 Nov
Gastrointestinal Cancers

ACCC Oncology Reimbursement Meeting - Providence

Association of Cancer Care Centers (ACCC)

10 Nov
ACCC Oncology

ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona

European Society For Medical Oncology (ESMO)

11 Nov
Brain Metastases

AACR Frontiers in Cancer Science 2026

American Association for Cancer Research

11 Nov
Cancer Science 2026

The Milken Institute Future of Health Summit 2026

Milken Institute

11 Nov
Future of Health Summit

Immune-oncology
Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era

Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era

10 Must-Read Posts in Immuno-Oncology This Week

Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment

KEYFORM-007: Dual PD-1/LAG-3 Blockade in MSS Colorectal Cancer

Agentic AI for Immune-Related Adverse Event Detection in Cancer Immunotherapy

Can the Tumor’s Own B Cells Reveal the Next Immunotherapy Target?

ESMO 2026: The Key Pembrolizumab Trials to Know

Gastrointestinal-Oncology
ABC-06

ABC-06 Trial: Prognostic Tumour Markers and Quality of Life With Second-Line FOLFOX in Advanced BTC

PRECEDE Study: Pancreatic Imaging Findings During Surveillance in BRCA1, BRCA2, ATM, and PALB2 Heterozygotes

Advanced Biliary Tract Cancer: Real-World Outcomes of First-Line Chemoimmunotherapy and Subsequent Targeted Therapy

NICHE-2: Long-Term Survival Outcomes With Neoadjuvant Immunotherapy in dMMR Colon Cancer

UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer

10 Must-Read Posts in GI Oncology This Week

Top Gastroesophageal Cancer Updates From ESMO 2026

Breast-Oncology
DESTINY-Breast09

DESTINY-Breast09 Redefines First-Line HER2-Positive Breast Cancer: Balancing Efficacy, Safety, and Treatment Selection

From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer

Neoadjuvant Carboplatin Improves Event-Free Survival in Early TNBC: Pooled Analysis of Three Randomized Trials Strengthens the Evidence

SABCS 2026: The Top 10 Breast Cancer Studies to Watch for Potential Practice-Changing Results

Trastuzumab Deruxtecan Secures EU Approval for Residual HER2-Positive Early Breast Cancer Following DESTINY-Breast05 Survival-Free Disease Benefit

A New Chance to Prevent Recurrence: EU Approves Trastuzumab Deruxtecan for HER2-Positive Early Breast Cancer

Biomarker Landscape of ADCs and Bispecific Antibodies in Breast Cancer: The 2026 Clinical Trial Breakthroughs and Future of Precision Treatment

Lung-Oncology
Lung Cancer

Small Cell Lung Cancer in Algeria in 2026: A Chemosensitive Disease That Leaves Little Room for Delay

Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR

LungÕ 2026: Integrating Care and Advancing Treatment for Locally Advanced Lung Cancer

Tarlatamab-Associated Neurotoxicity in SCLC: New Study Identifies TIAN in Patients With Brain Metastases

Neoadjuvant Immunotherapy Linked to Improved Five-Year Survival in Resected NSCLC: Real-World Study Supports Long-Term Benefit Without Increased Surgical Morbidity

Biomarker Landscape of ADCs and Bispecific Antibodies in Lung Cancer: The 2026 Clinical Trial Evidence and Future of Precision Treatment

ASCO 2026.3.4 Living Guideline: Lorlatinib Takes Priority in First-Line ALK-Positive NSCLC After Landmark Seven-Year CROWN Results

OncoDaily TV
Dr Gevorg Tamamyan

Dr Gevorg Tamamyan Welcomes Prof Cesaltina Lorenzoni, President of AORTIC, to the International Advisory Board of WHO Director-General Campaign

Dr Gevorg Tamamyan

Mongolia’s Former Minister of Health Dr Chinburen Jigjidsuren Will Join the International Advisory Board of Dr Gevorg Tamamyan’s WHO DG Campaign

Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Not To Miss
LungÕ 2026

LungÕ 2026: Global Experts Examine the Changing Landscape of Lung Cancer Care

SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia

Genmab’s Phase 3 LiGeR-HN1 Trial Met Primary Endpoints of Overall Survival and Response Rate in HNSCC

Geneva Health Files Interviews Gevorg Tamamyan on WHO Reform and Global Health Leadership

Reed Jobs’ Yosemite Raises $350 Million to Support Cancer Research

The LIFT Trial: Proving the Power of Embedded Financial Navigators in Rural and Urban Oncology

Health Policy Watch Examines Gevorg Tamamyan’s WHO Bid

OncoGrants
ONS Congress Scholarship

ONS Congress Scholarship 2027

Cancer Research Grant

Elsa U. Pardee Foundation Cancer Research Grant

Translational Research Award

IMS–Paula and Rodger Riney Foundation Translational Research Award 2027

Barbara S. Goodman

ICRF Barbara S. Goodman Pancreatic Cancer Award 2027–2028

Research Scholar Grants

American Cancer Society Research Scholar Grants 2026

Rodger Riney Foundation

IMS–Paula and Rodger Riney Foundation Career Development Award 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Ruzanna Papyan

Ruzanna Papyan

Oncologists Location Yerevan, Armenia
Leandro Jonata de Carvalho Oliveira

Leandro Jonata de Carvalho Oliveira

Oncologists Location São Paulo, Brazil
Roberto Carmagnani Pestana

Roberto Carmagnani Pestana

Oncologists Location São Paulo, Brazil
Antonio Lázaro Sánchez

Antonio Lázaro Sánchez

Oncologists Location El Palmar, Spain
Dilyara Kaidarova

Dilyara Kaidarova

Oncologists Location Almaty, Kazakhstan
Zulfiquer Otty

Zulfiquer Otty

Oncologists Location Townsville, Australia
Ghassan Abou-Alfa

Ghassan Abou-Alfa

Oncologists Location New York, USA
Gabriëlle van Ramshorst

Gabriëlle van Ramshorst

Oncologists Location Ghent, Belgium

Drugs Atlas
Bevacizumab (Avastin): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Bevacizumab (Avastin) Nov 6, 2026 4:49 pm
Panitumumab (Vectibix): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Panitumumab (Vectibix) Nov 5, 2026 1:18 pm
Cetuximab (Erbitux): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Cetuximab (Erbitux) Nov 5, 2026 1:14 pm
Margetuximab (Margenza): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Margetuximab (Margenza) Nov 5, 2026 1:09 pm
Pertuzumab (Perjeta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Pertuzumab (Perjeta) Nov 3, 2026 9:23 am
Trastuzumab (Herceptin): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Trastuzumab (Herceptin) Nov 2, 2026 5:11 pm
Ofatumumab (Arzerra, Kesimpta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Ofatumumab (Arzerra, Kesimpta) Nov 1, 2026 1:25 am
Obinutuzumab (Gazyva): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Obinutuzumab (Gazyva; Gazyvaro) Nov 1, 2026 1:23 am
Sotorasib (Lumakras; AMG 510): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in KRAS G12C-Mutated Lung and Colorectal Cancer Sotorasib (Lumakras; AMG 510) Oct 31, 2026 6:38 am
Rituximab (Rituxan; MabThera): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in B-Cell Malignancies and Autoimmune Diseases Rituximab (Rituxan; MabThera) Oct 31, 2026 6:37 am

OncoDaily Magazine

New Paper Alert
Kim Nichols

Kim Nichols Shares New Guideline on Genetic Testing for Childhood Cancer Survivors

Achille Manirakiza

Achille Manirakiza: A Prehistoric BRCA1 Founder Variant in Rwanda

Luis Álvarez-Vallina

Luis Álvarez-Vallina’s STAb-T Research Takes the Spotlight in Advanced Science

Jia Liu

Jia Liu: Are We Measuring the Full Benefit of ADCs in Cancer Treatment?

Narjust Florez

Narjust Florez: TKIs in Pregnancy for Lung Cancer

Stephen Liu

Stephen Liu: TKI-Based Induction Therapy Enables Surgery in Initially Unresectable EGFR-Mutant NSCLC

OncoDaily Medical Journal

GU Oncology

10.69690/ODMJ-001-1026-8269

Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis
Original Research

Pediatric Oncology

10.69690/ODMJ-001-1026-8309

Limited Prognostic Value of Baseline Curie Score in Children with High-Risk Neuroblastoma Treated with Contemporary Multi-modal Therapy: A Single-Center Retrospective Cohort Study
Original Research

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews